These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 10631520)

  • 21. Leukocytoclastic vasculitis induced by low-dose methotrexate: in vitro evidence for an immunologic mechanism.
    Halevy S; Giryes H; Avinoach I; Livni E; Sukenik S
    J Eur Acad Dermatol Venereol; 1998 Jan; 10(1):81-5. PubMed ID: 9552765
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Primary cutaneous small vessel vasculitis: approach to diagnosis and treatment.
    Russell JP; Gibson LE
    Int J Dermatol; 2006 Jan; 45(1):3-13. PubMed ID: 16426368
    [No Abstract]   [Full Text] [Related]  

  • 23. Antiphospholipids--a "guilty ghost" syndrome.
    Vayssairat M; Abuaf N; Gaitz JP; Baudot N
    Clin Rev Allergy Immunol; 1995; 13(1):1-4. PubMed ID: 7648343
    [No Abstract]   [Full Text] [Related]  

  • 24. Antiphospholipid antibodies.
    Houghton DE; Moll S
    Vasc Med; 2017 Dec; 22(6):545-550. PubMed ID: 29103369
    [No Abstract]   [Full Text] [Related]  

  • 25. Clinical performance (sensitivity and agreement with thrombosis) of four antiphospholipid antibody assays.
    Lopez LR; Whittier AM; Dier KJ; Taylor DO; Buckner TR; Olsen LW; Fink CA
    Am Clin Lab; 2002 Apr; 21(3):41-4. PubMed ID: 12038085
    [No Abstract]   [Full Text] [Related]  

  • 26. [The antiphospholipid syndrome and antiphospholipid antibodies].
    Malícková K; Fucíková T
    Cas Lek Cesk; 2001 Aug; 140(15):465-8. PubMed ID: 11569167
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Primary anetoderma is a cutaneous sign of antiphospholipid antibodies.
    Hodak E; Feureman H; David M
    J Am Acad Dermatol; 2008 Feb; 58(2):351. PubMed ID: 18222336
    [No Abstract]   [Full Text] [Related]  

  • 28. IgA antineutrophil cytoplasmic antibodies in cutaneous vasculitis.
    Rovel-Guitera P; Diemert MC; Charuel JL; Laporte JL; Musset L; Chosidow O; Piette JC; Francès C
    Br J Dermatol; 2000 Jul; 143(1):99-103. PubMed ID: 10886142
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cutaneous vasculitis in a defined population--clinical and epidemiological associations.
    Watts RA; Jolliffe VA; Grattan CE; Elliott J; Lockwood M; Scott DG
    J Rheumatol; 1998 May; 25(5):920-4. PubMed ID: 9598892
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Initial cutaneous manifestations associated with histopathological leukocytoclastic vasculitis in two patients with antiphospholipid antibody syndrome.
    Kawakami T; Soma Y; Mizoguchi M
    J Dermatol; 2005 Dec; 32(12):1032-7. PubMed ID: 16471472
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Criteria for the diagnosis of antiphospholipid syndrome in patients presenting with dermatologic symptoms.
    Kriseman YL; Nash JW; Hsu S
    J Am Acad Dermatol; 2007 Jul; 57(1):112-5. PubMed ID: 17467850
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Dermatologic manifestations of the antiphospholipid syndrome].
    Francès C; Barete S; Soria A
    Rev Med Interne; 2012 Apr; 33(4):200-5. PubMed ID: 22078802
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antiphospholipid antibodies and the antiphospholipid antibody syndrome.
    Nahass GT
    J Am Acad Dermatol; 1997 Feb; 36(2 Pt 1):149-68; quiz 169-72. PubMed ID: 9039162
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Migraine in patients with stroke and antiphospholipid antibodies.
    Silvestrini M; Cupini LM; Matteis M; De Simone R; Bernardi G
    Headache; 1993 Sep; 33(8):421-6. PubMed ID: 8262781
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical features and pathogenesis of catastrophic antiphospholipid syndrome.
    Kaburaki J
    Intern Med; 2000 Oct; 39(10):763-4. PubMed ID: 11030196
    [No Abstract]   [Full Text] [Related]  

  • 36. Unusual clinical presentations of vasculitis: what some clinical aspects can tell us about the pathogenesis.
    Papi M; Didona B
    Clin Dermatol; 1999; 17(5):559-64. PubMed ID: 10590849
    [No Abstract]   [Full Text] [Related]  

  • 37. New basic aspects of the antiphospholipid syndrome.
    Hunt JE; Adelstein S; Krilis SA
    Clin Exp Rheumatol; 1994; 12(6):661-8. PubMed ID: 7895403
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The spectrum of the antiphospholipid syndrome: a matter of perspective.
    Clark CA; Spitzer KA; Laskin CA
    J Rheumatol; 2001 Sep; 28(9):1939-41. PubMed ID: 11550956
    [No Abstract]   [Full Text] [Related]  

  • 39. Chronic hepatitis C, cryoglobulinemia, and cutaneous necrotizing vasculitis. Clinical, pathologic, and immunopathologic study of twelve patients.
    Daoud MS; el-Azhary RA; Gibson LE; Lutz ME; Daoud S
    J Am Acad Dermatol; 1996 Feb; 34(2 Pt 1):219-23. PubMed ID: 8642085
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Frequent difficulties encountered in the laboratory diagnosis of antiphospholipid-protein antibodies.
    Triplett DA
    Ann Med Interne (Paris); 1996 Sep; 147 Suppl 1():5-9. PubMed ID: 8952751
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.